“Hear Up to 30 Times Better” Was a Number Nobody Could Actually Prove

A Florida company sold a personal sound amplifier called the MSA 30X with television commercials built around a simple, relatable scene: an older man's wife is tired of the television being too loud, and once he starts using the device, he can hear clearly at a normal volume. The ads claimed the product was “independently tested to help you hear up to 30 times better.” According to the Federal Trade Commission, that specific number, and the independent testing behind it, did not exist.DOCUMENTED

Global Concepts Limited, Inc., along with related entities GCL Product Holdings, LLC and MSA 30X LLC, and their principal owner, Laurie Braden, agreed to a court order settling the FTC's charges, barring the company from making similar unsupported claims going forward.DOCUMENTED

What the complaint alleges

According to the FTC's complaint, the defendants deceptively advertised the MSA 30X nationwide in violation of the FTC Act, with television ads and matching website claims asserting the device was independently tested to help users hear dramatically better than they could unassisted.DOCUMENTED The FTC alleges the company did not possess adequate evidence that the amplifier actually helped consumers hear better in the specific situations depicted in the ads — crowded restaurants, a living room with the television turned down — nor did it have independent testing to support the specific, quantified “up to 30 times better” claim that gave the product its name.DOCUMENTED

Why a specific number carries more weight than a vague claim

Advertising a product as helping users “hear better” in general terms is a softer, harder-to-disprove claim than advertising a specific multiplier like “30 times better,” which implies a precise, measured comparison between using the device and not using it.REVIEWED That specificity is part of what made the underlying claim actionable: a number presented as the output of independent testing invites a direct evidentiary question — where is that test, and does its result match the number in the ad — that a vaguer claim about improved hearing generally would not raise in the same way.

Sound amplifiers versus hearing aids

Personal sound amplification products like the MSA 30X are legally distinct from medical hearing aids, which require FDA clearance and are intended to compensate for diagnosed hearing impairment. Amplifiers are marketed for use by people with normal hearing in situations where amplification is simply convenient, such as birdwatching or watching television at a distance.REVIEWED That regulatory distinction does not exempt amplifier marketers from ordinary advertising substantiation requirements, however — a company can sell a legal, unregulated sound amplifier while still being liable for making a specific performance claim about that product that it cannot actually support.

Why the target audience mattered

The FTC's description of the ads specifically notes they featured older consumers frustrated by common hearing-related situations — a restaurant conversation, a spouse complaining about television volume — scenarios designed to resonate with an older audience experiencing the normal, gradual hearing changes that come with age.REVIEWED That audience is also one more likely to be evaluating the product as a genuine alternative to a costlier, more clinically rigorous hearing aid, making an unsubstantiated performance claim particularly consequential for someone who might otherwise have sought a diagnosed hearing solution instead.

Terms of the settlement

Under the court order, the defendants are barred from claiming that the MSA 30X or any similar product has been independently tested to produce a specific level of improved hearing, unless that claim is true and backed by the kind of competent and reliable evidence the FTC Act requires for this type of performance claim.DOCUMENTED The order separately prohibits the defendants from representing that any claim is based on scientific evidence when it is not, a broader restriction covering future products beyond the specific MSA 30X device named in the original complaint.DOCUMENTED

The ad's central promise — hearing “up to 30 times better” — was not backed by the kind of independent testing the marketing claimed stood behind it, according to the FTC.

Why the case matters

For consumers evaluating any personal sound amplifier or similar hearing-adjacent product, the case is a reminder that a precise, quantified performance claim — a specific multiplier, percentage, or comparison — is exactly the kind of assertion that should be checked against actual, named testing before purchase, rather than accepted simply because it sounds more scientific than a vaguer marketing phrase.

How the case fits a broader pattern in aging-focused advertising

Products marketed toward age-related conditions frequently pair a genuinely useful underlying technology with an overstated performance claim layered on top, since the underlying product category is legitimate enough to survive scrutiny of the device itself while the specific advertised number becomes the actual point of legal exposure. That pattern recurs across hearing, vision, and mobility products marketed to older consumers, making the specific, quantified claim — not the product category as a whole — the detail regulators and consumers alike should scrutinize most closely.

What consumers can check before buying a similar product

Consumers evaluating any personal sound amplifier or comparable device can reasonably ask the seller to identify the specific laboratory or testing organization behind any performance claim, and can independently search for that organization's name before purchasing. A company unable or unwilling to name the actual source of an "independently tested" claim is, as this case shows, sometimes making a claim with no real testing behind it at all.

Have documents relevant to this story? Reach us through our tips channel.